scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Chunying Li | |
Anjaparavanda P Naren | |||
P433 | issue | 2 | |
P921 | main subject | cystic fibrosis | Q178194 |
macromolecule | Q178593 | ||
transmembrane protein | Q424204 | ||
P304 | page(s) | 208-223 | |
P577 | publication date | 2005-06-02 | |
P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
P1476 | title | Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners | |
P478 | volume | 108 |
Q36981695 | A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating |
Q24309321 | A noncanonical SH3 domain binding motif links BK channels to the actin cytoskeleton via the SH3 adapter cortactin |
Q36352495 | ABC transporter architecture and regulatory roles of accessory domains |
Q89108031 | AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera |
Q89985483 | Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis-causing mutation |
Q35228705 | Analysis of CFTR interactome in the macromolecular complexes |
Q37503665 | Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia |
Q37373358 | Assessment of the CFTR and ENaC association |
Q37133567 | CFTR activity and mitochondrial function |
Q37288563 | CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis |
Q34340439 | CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners |
Q41660999 | CFTR-NHERF2-LPA₂ Complex in the Airway and Gut Epithelia |
Q36015274 | CFTR-SLC26 transporter interactions in epithelia |
Q37129332 | CLC-0 and CFTR: chloride channels evolved from transporters |
Q38104753 | Cholera: pathophysiology and emerging therapeutic targets |
Q33721181 | Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains |
Q34701465 | Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis |
Q35169502 | Defective adenosine-stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling |
Q33409811 | Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice |
Q38233032 | Disease-modifying genes and monogenic disorders: experience in cystic fibrosis |
Q79908763 | Down regulation of small intestinal ion transport in PDZK1- (CAP70/NHERF3) deficient mice |
Q26753851 | Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers |
Q47781167 | Evidence that extracellular anions interact with a site outside the CFTR chloride channel pore to modify channel properties |
Q28251491 | Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1 |
Q41540235 | Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages |
Q30998341 | Functional regulation of cystic fibrosis transmembrane conductance regulator-containing macromolecular complexes: a small-molecule inhibitor approach |
Q64376611 | Gene therapy for cystic fibrosis |
Q38748484 | Human airway epithelial cells investigated by atomic force microscopy: A hint to cystic fibrosis epithelial pathology. |
Q35122818 | Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP |
Q36809350 | Interactions of connexins with other membrane channels and transporters |
Q36704481 | Investigating membrane protein dynamics in living cells |
Q42498791 | Ion channel function of aquaporin-1 natively expressed in choroid plexus. |
Q36418881 | Keratin K18 increases cystic fibrosis transmembrane conductance regulator (CFTR) surface expression by binding to its C-terminal hydrophobic patch |
Q33489607 | Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice |
Q41819454 | Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses |
Q28572915 | Lubiprostone stimulates duodenal bicarbonate secretion in rats |
Q36796953 | MAST205 competes with cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand for binding to CFTR to regulate CFTR-mediated fluid transport |
Q41856265 | Mechanistic insight into control of CFTR by AMPK. |
Q40181305 | NHE-RF1 protein rescues DeltaF508-CFTR function. |
Q39281815 | NHERF1 and CFTR restore tight junction organisation and function in cystic fibrosis airway epithelial cells: role of ezrin and the RhoA/ROCK pathway. |
Q33571668 | Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells |
Q37140714 | Nasal potential difference measurements to assess CFTR ion channel activity |
Q56680230 | New insights into cystic fibrosis: molecular switches that regulate CFTR |
Q93087049 | Phosphorylation-dependent modulation of CFTR macromolecular signalling complex activity by cigarette smoke condensate in airway epithelia |
Q36356523 | Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia |
Q39541029 | Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer. |
Q36787231 | Proteomic biomarker discovery for the monogenic disease cystic fibrosis |
Q49284664 | Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis |
Q36481817 | Reduced PDZ interactions of rescued ΔF508CFTR increases its cell surface mobility. |
Q36286123 | Role of binding and nucleoside diphosphate kinase A in the regulation of the cystic fibrosis transmembrane conductance regulator by AMP-activated protein kinase |
Q40149608 | Role of the scaffold protein RACK1 in apical expression of CFTR. |
Q33493069 | Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity |
Q36405047 | Signaling protein complexes associated with neuronal ion channels |
Q42144741 | Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia |
Q27682058 | Structural insights into PDZ-mediated interaction of NHERF2 and LPA2, a cellular event implicated in CFTR channel regulation |
Q40198458 | Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach |
Q24657572 | The ABC protein turned chloride channel whose failure causes cystic fibrosis |
Q51080366 | The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9. |
Q36985840 | The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor |
Q37827577 | The cystic fibrosis transmembrane conductance regulator's expanding SNARE interactome |
Q33381294 | The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model |
Q41893473 | The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling |
Q33844906 | Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: implications for lung cancer |
Q30478396 | Tracking of quantum dot-labeled CFTR shows near immobilization by C-terminal PDZ interactions |
Q37234581 | Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway |
Q38996193 | Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells. |
Q38005772 | Vitamin D bioavailability in cystic fibrosis: a cause for concern? |
Search more.